Search Result "mTOR inhibitors"


Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

Journal: Current Cancer Drug Targets
Volume: 4 Issue: 8 Year: 2004 Page: 621-635
Author(s): Ravi D. Rao, Jan C. Buckner, Jann N. Sarkaria

Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4 Issue: 5 Year: 2004 Page: 449-455
Author(s): Tomi K. Sawyer

Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes

Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1105-1137
Author(s): Allan S. Wagman, Kirk W. Johnson, Dirksen E. Bussiere

Preface [Hot Topic: Emerging Kinase Targets and Kinase Inhibitor Discovery Methods (Guest Editor: Gary McCort)]

Journal: Current Medicinal Chemistry
Volume: 11 Issue: 6 Year: 2004 Page: ii-ii
Author(s): Gary McCort

Phosphoinositide 3-Kinases as Targets for Therapeutic Intervention

Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1915-1922
Author(s): Reinhard Wetzker, Christian Rommel

The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

Journal: Current Cancer Drug Targets
Volume: 4 Issue: 3 Year: 2004 Page: 235-256
Author(s): Constantine S. Mitsiades, Nicholas Mitsiades, Michael Koutsilieris

Imatinib (STI571) Resistance in Chronic Myelogenous Leukemia: Molecular Basis of the Underlying Mechanisms and Potential Strategies for Treatment

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4 Issue: 3 Year: 2004 Page: 285-299
Author(s): Sandra W. Cowan-Jacob, Valerie Guez, Gabriele Fendrich, James D. Griffin, Doriano Fabbro, Pascal Furet, Janis Liebetanz, Jurgen Mestan, Paul W. Manley

Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics

Journal: Current Proteomics
Volume: 1 Issue: 2 Year: 2004 Page: 83-102
Author(s): Benjamin K. Benton, Christian Rommel, Mark Velleca, Christian Pasquali

Preface [Hot Topic: Signal Transduction Therapy: Facts and Visions Executive Editor: Claus Liebmann ]

Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: ii-ii
Author(s): Claus Liebmann

AKT: A Potential Target for Thyroid Cancer Therapy

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 4 Issue: 3 Year: 2004 Page: 181-185
Author(s): Faiza Kada, Motoyasu Saji, Matthew D. Ringel

Previous   Next

Go To   Results 1 - 1 of 18

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy